Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia ...

A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...

Diagnosing Parkinson's disease has always been a race against time. The later it’s found, the harder it is to treat.